Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 Jul 31;17(7):4379-4382.
doi: 10.21037/jtd-2025-769. Epub 2025 Jul 29.

Exacerbation control in chronic obstructive pulmonary disease with tezepelumab: insights from the COURSE trial

Dil Afrose  1 , Melika Valizadeh  2 , Pradeesh Sivapalan  1   3
Affiliations
Editorial

Exacerbation control in chronic obstructive pulmonary disease with tezepelumab: insights from the COURSE trial

Dil Afrose et al. J Thorac Dis. .
No abstract available

Keywords: Clinical trial; chronic obstructive pulmonary disease (COPD); monoclonal antibody; tezepelumab; thymic stromal lymphopoietin (TSLP).

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://jtd.amegroups.com/article/view/10.21037/jtd-2025-769/coif). The authors have no conflicts of interest to declare.

Comment on

References

    1. Singh D, Brightling CE, Rabe KF, et al. Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial. Lancet Respir Med 2025;13:47-58. 10.1016/S2213-2600(24)00324-2 - DOI - PubMed
    1. Yadav AK, Gu W, Zhang T, et al. Current Perspectives on Biological Therapy for COPD. COPD 2023;20:197-209. 10.1080/15412555.2023.2187210 - DOI - PubMed
    1. Calderon AA, Dimond C, Choy DF, et al. Targeting interleukin-33 and thymic stromal lymphopoietin pathways for novel pulmonary therapeutics in asthma and COPD. Eur Respir Rev 2023;32:220144. 10.1183/16000617.0144-2022 - DOI - PMC - PubMed
    1. Roan F, Obata-Ninomiya K, Ziegler SF. Epithelial cell-derived cytokines: more than just signaling the alarm. J Clin Invest 2019;129:1441-51. 10.1172/JCI124606 - DOI - PMC - PubMed
    1. Saber Cherif L, Devilliers MA, Perotin JM, et al. Airway epithelial TSLP production is increased in COPD patients. Eur Respir J 2023;62:PA611.